M

Mark A. Perrella

Brigham and Women's Hospital

ORCID: 0000-0002-7219-7688

Publishes on Heme Oxygenase-1 and Carbon Monoxide, Nitric Oxide and Endothelin Effects, Eicosanoids and Hypertension Pharmacology. 240 papers and 17.6k citations.

PubIndex Score98Top 2%How it's scored

240Publications

17.6kTotal Citations

First publication: 1975First senior author: 1997

Heme Oxygenase-1 and Carbon Monoxide Nitric Oxide and Endothelin Effects Eicosanoids and Hypertension Pharmacology Cell Adhesion Molecules Research Mesenchymal stem cell research

Top publicationsby citations

Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.

J Tsai, M E Lee, Mark A. Perrella et al.|Proceedings of the National Academy of Sciences|1994

Cited by 806

Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.

M Yoshizumi, M E Lee, Mark A. Perrella et al.|Circulation Research|1993

Cited by 776

Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP.

Toshihiro Morita, Stella Kourembanas, Mark A. Perrella et al.|Proceedings of the National Academy of Sciences|1995

Cited by 710

Natriuretic peptide system in human heart failure.

Chao Wei, John C. Burnett, Denise M. Heublein et al.|Circulation|1993

Cited by 461

Lipoxin A <sub>4</sub> Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell Activation in Asthma

Cindy Barnig, Bruce D. Levy, Manuela Cernadas et al.|Science Translational Medicine|2013

Cited by 441